@misc{indiciaee01a7e183943,
  title = {Structural and functional analysis of lorlatinib analogs reveals roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer},
  author = {Shiba-Ishii, A. and Johnson, T. W. and Dagogo-Jack, I. and Mino-Kenudson, M. and Johnson, T. R. and Wei, P. and Weinrich, S. L. and McTigue, M. A. and Walcott, M. A. and Nguyen-Phuong, L. and Dionne, K. and Acker, A. and Kiedrowski, L. and Do, A. and Peterson, J. L. and Barth, J. L. and Yeap, B. Y. and Gainor, J. F. and Lin, J. J. and Yoda, S. and Hata, A. N.},
  year = {2021},
  doi = {10.1101/2021.07.16.452681},
  url = {https://www.biorxiv.org/content/10.1101/2021.07.16.452681v1},
  note = {Source identifier: 10.1101/2021.07.16.452681}
}